Skip to main content
Log in

Neoadjuvante Chemotherapie in retroperitonealen Sarkomen

Neoadjuvant chemotherapy for retroperitoneal sarcoma

  • Journal Club
  • Published:
Die Chirurgie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Haas R et al (2022) Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092-22092 STRASS trial. Cancer 128:2796–2805

    Article  PubMed  Google Scholar 

  2. Callegaro D et al (2021) Has the outcome for patients who undergo resection of primary retroperitoneal sarcoma changed over time? A study of time trends during the past 15 years. Ann Surg Oncol 28:1700–1709

    Article  PubMed  Google Scholar 

  3. Bonvalot S et al (2019) Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a nationwide study of the French sarcoma group from the netSarc database. Ann Surg Oncol 26:2286–2293

    Article  CAS  PubMed  Google Scholar 

  4. Schmitz R, Adam MA, Blazer DG (2019) Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival. World J Surg Onc 17:180

    Article  Google Scholar 

  5. Keung EZ et al (2018) Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer 124:4495–4503

    Article  PubMed  Google Scholar 

  6. Pasquali S et al (2022) Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: a Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer 128:85–93

    Article  CAS  PubMed  Google Scholar 

  7. [S3 Guideline ‘Adult soft tissue sarcomas’]. Chirurg 93, 520 (2022).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph Reissfelder MHBA.

Ethics declarations

Interessenkonflikt

C. Yang, J. Jakob und C. Reissfelder geben an, dass kein Interessenkonflikt besteht.

Additional information

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, C., Jakob, J. & Reissfelder, C. Neoadjuvante Chemotherapie in retroperitonealen Sarkomen. Chirurgie 95, 491–492 (2024). https://doi.org/10.1007/s00104-024-02099-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-024-02099-6

Navigation